The Multiple Myeloma Channel is supported with funding from AbbVie (Platinum), Sanofi (Gold), Legend Biotech (Bronze), and through an educational grant from Alexion Pharma GmbH.
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESH MM 2018 | The evolving imaging of multiple myeloma
Speaking from the European School of Haematology (ESH) International Conference on Multiple Myeloma 2018, held in Mandelieu, France, Evangelos Terpos, MD, PhD, of the University of Athens, Athens, Greece, discusses the evoling field of imaging in multiple myeloma, including PET/CT, full body MRI and diffusion weighted imaging. Dr Terpos also highlights the new standard of imaging for measurable residual disease.
